Latest News

Lenabasum, a cannabinoid receptor agonist, is an effective and safe treatment for amyopathic dermatomyositis

According to a phase 2 clinical trial published in the Journal of Investigative Dermatology this well-tolerated medication offers the first oral therapeutic option specifically for the skin-only form of this autoimmune condition (September 21, 2022)

View the complete news release [pdf]

Epidural nerve block with lidocaine leads to clearance of psoriatic skin lesions

In this novel proof-of-concept study, investigators report in the Journal of Investigative Dermatology on a new approach in treating psoriasis using an epidural nerve block with lidocaine (August 10, 2022)

View the complete news release [pdf]

Studies of COVID-19 risk in patients with psoriasis and psoriatic arthritis appear biased

In the midst of the pandemic, the hunger for data and desire to provide swift information may have lowered the quality of research, investigators report in the Journal of Investigative Dermatology (August 4, 2021)

View the complete news release [pdf]

Erwin Tschachler, MD, appointed Editor-Elect of the Journal of Investigative Dermatology

(May 20, 2021)

View the complete news release [pdf]

Elsevier Launches JID Innovations: Skin Science from Molecules to Population Health

New open access, peer-reviewed, online-only journal to serve the needs of the global dermatology community (September 29, 2020)

View the complete news release [pdf]

Researchers develop new microneedle array combination vaccine delivery system

Novel vaccine delivery technology will contribute to efforts to develop universal vaccines and improve global immunization capabilities essential for combating coronavirus, reports the Journal of Investigative Dermatology (April 21, 2020)

View the complete news release [pdf]

New artificial intelligence system can empower medical professionals in diagnosing skin diseases

Researchers have developed an AI algorithm capable of diagnosing 134 skin disorders and supporting specialists by augmenting the accuracy of diagnoses and predicting treatment options, reports the Journal of Investigative Dermatology (March 31, 2020)

View the complete news release [pdf]

Increased depression, suicidal thoughts and stress are reported in patients with chronically itchy skin

A new multicenter European study that assessed the burden of itch on dermatological patients' psychological wellbeing is reported in the Journal of Investigative Dermatology (October 29, 2019)

View the complete news release [pdf]

How do ketogenic diets affect skin inflammation?

A study in the Journal of Investigative Dermatology tested several high-fat, low-carb ketogenic diets and found those high in coconut and palm oils exacerbated psoriasiform-like skin inflammation in mice. (October 17, 2019)

View the complete news release [pdf]

Novel strategy using microRNA biomarkers can distinguish melanomas from nevi

Melanoma is the least common but one of the most deadly skin cancers. It accountsfor only about one percent of all cases globally, but the majority of skin cancer deaths. Accurate, timely and reliable diagnosis of cutaneous melanoma remains a significant challenge in dermatopathology. Investigators report on a novel strategy for using microRNA biomarkers to detect melanoma cells in skin tumors even when the tumor contains predominantly benign cells. (September 30, 2019)

Read the complete release here [pdf]

Mode of delivery at birth may play key role in shaping the child’s skin microbiome

The bacterial population children’s skin is to a large extent similar to that of their mothers and is affected in the long term by whether they were born by vaginal delivery or Caesarian section, report scientists in the Journal of Investigative Dermatology (August 13, 2019)

View the complete news release [pdf]

Jefferson Matrix Biology and Pathology Symposium

SAVE THE DATE!
May 22–24, 2019
Jefferson Institute of Molecular Medicine
Thomas Jefferson University, Philadelphia, PA

View the complete announcement [pdf]

Realistic exposure study supports the use of zinc oxide nanoparticle sunscreens

New risk assessment may help allay safety concerns, according to an important study conducted in Australia, reported in the Journal of Investigative Dermatology (December 4, 2018)

View the complete news release [pdf]

Advertisement